BACKGROUND: The impact of narcotic use before kidney transplantation on post-transplant clinical outcomes is not well described. METHODS: We examined integrated national transplant registry, pharmacy records, and Medicare billing claims to follow 16,322 kidney transplant recipients, of whom 28.3% filled a narcotic prescription in the year before transplantation. Opioid analgesic fills were normalized to morphine equivalents (ME) and expressed as mg/kg exposures (approximate quartiles: 0.1-1.7, 1.8-5.4, 5.5-23.7, and ≥ 23.8 mg/kg, respectively). Post-transplant cardiovascular, respiratory, neurological, accidents, substance abuse, and noncompliance events were identified using diagnosis codes on Medicare billing claims. Adjusted associations of ME level with post-transplant complications were quantified by multivariate Cox regression. RESULTS: The incidence of complications at 3 years post-transplant among those with the highest pre-transplant ME exposure compared to no use included: ventricular arrhythmias, 1.1 vs. 0.2% (p < 0.001); cardiac arrest, 4.7 vs. 2.7% (p < 0.05); hypotension, 14 vs. 8% (p < 0.0001); hypercapnia, 1.6 vs. 0.9% (p < 0.05); mental status changes, 5.3 vs. 2.7% (p < 0.001); drug abuse/dependence, 7.0 vs. 1.7% (p < 0.0001); alcohol abuse, 1.8 vs. 0.6% (p = 0.0001); accidents, 0.9 vs. 0.3% (p < 0.05); and noncompliance, 3.5 vs. 2.3% (p < 0.05). In multivariate analyses, transplant recipients with the highest level of pre-transplant narcotic use had approximately 2 to 4 times the risks of post-transplant ventricular arrhythmias, mental status changes, drug abuse, alcohol abuse, and accidents compared with non-users, and 35-45% higher risks of cardiac arrest and hypotension. CONCLUSION: Although associations may reflect underlying conditions or behaviors, high-level prescription narcotic use before kidney transplantation predicts increased risk of clinical complications after transplantation.
BACKGROUND: The impact of narcotic use before kidney transplantation on post-transplant clinical outcomes is not well described. METHODS: We examined integrated national transplant registry, pharmacy records, and Medicare billing claims to follow 16,322 kidney transplant recipients, of whom 28.3% filled a narcotic prescription in the year before transplantation. Opioid analgesic fills were normalized to morphine equivalents (ME) and expressed as mg/kg exposures (approximate quartiles: 0.1-1.7, 1.8-5.4, 5.5-23.7, and ≥ 23.8 mg/kg, respectively). Post-transplant cardiovascular, respiratory, neurological, accidents, substance abuse, and noncompliance events were identified using diagnosis codes on Medicare billing claims. Adjusted associations of ME level with post-transplant complications were quantified by multivariate Cox regression. RESULTS: The incidence of complications at 3 years post-transplant among those with the highest pre-transplant ME exposure compared to no use included: ventricular arrhythmias, 1.1 vs. 0.2% (p < 0.001); cardiac arrest, 4.7 vs. 2.7% (p < 0.05); hypotension, 14 vs. 8% (p < 0.0001); hypercapnia, 1.6 vs. 0.9% (p < 0.05); mental status changes, 5.3 vs. 2.7% (p < 0.001); drug abuse/dependence, 7.0 vs. 1.7% (p < 0.0001); alcohol abuse, 1.8 vs. 0.6% (p = 0.0001); accidents, 0.9 vs. 0.3% (p < 0.05); and noncompliance, 3.5 vs. 2.3% (p < 0.05). In multivariate analyses, transplant recipients with the highest level of pre-transplant narcotic use had approximately 2 to 4 times the risks of post-transplant ventricular arrhythmias, mental status changes, drug abuse, alcohol abuse, and accidents compared with non-users, and 35-45% higher risks of cardiac arrest and hypotension. CONCLUSION: Although associations may reflect underlying conditions or behaviors, high-level prescription narcotic use before kidney transplantation predicts increased risk of clinical complications after transplantation.
Authors: Krista L Lentine; Hui Yuan; Janet E Tuttle-Newhall; Huiling Xiao; Vikram Chawa; David Axelrod; Daniel C Brennan; Vikas R Dharnidharka; Christopher Beuer; Mark A Schnitzler Journal: Transplantation Date: 2015-01 Impact factor: 4.939
Authors: S De Geest; L Borgermans; H Gemoets; I Abraham; H Vlaminck; G Evers; Y Vanrenterghem Journal: Transplantation Date: 1995-02-15 Impact factor: 4.939
Authors: Krista L Lentine; Abhijit S Naik; Rosemary Ouseph; Zidong Zhang; David A Axelrod; Dorry L Segev; Vikas R Dharnidharka; Daniel C Brennan; Henry Randall; Raj Gadi; Ngan N Lam; Gregory P Hess; Bertram L Kasiske; Mark A Schnitzler Journal: Transpl Int Date: 2017-08-03 Impact factor: 3.782
Authors: Kevin C Abbott; Chyng-Wen Fwu; Paul W Eggers; Anne W Eggers; Prudence P Kline; Paul L Kimmel Journal: Transplantation Date: 2018-06 Impact factor: 4.939
Authors: Luke S Vest; Nagaraju Sarabu; Farrukh M Koraishy; Minh-Tri Nguyen; Meyeon Park; Ngan N Lam; Mark A Schnitzler; David Axelrod; Chi Yuan Hsu; Amit X Garg; Dorry L Segev; Allan B Massie; Gregory P Hess; Bertram L Kasiske; Krista L Lentine Journal: Clin Transplant Date: 2020-06-29 Impact factor: 2.863
Authors: K L Lentine; N N Lam; A S Naik; D A Axelrod; Z Zhang; V R Dharnidharka; G P Hess; D L Segev; R Ouseph; H Randall; T Alhamad; R Devraj; R Gadi; B L Kasiske; D C Brennan; M A Schnitzler Journal: Am J Transplant Date: 2018-04-17 Impact factor: 8.086
Authors: Krista L Lentine; Kevin S Shah; Jon A Kobashigawa; Huiling Xiao; Zidong Zhang; David A Axelrod; Ngan N Lam; Dorry L Segev; Mara Ann McAdams-DeMarco; Henry Randall; Gregory P Hess; Hui Yuan; Luke S Vest; Bertram L Kasiske; Mark A Schnitzler Journal: Am J Transplant Date: 2019-09-12 Impact factor: 8.086
Authors: Marie A Chisholm-Burns; Christina A Spivey; Praveen K Potukuchi; Elani Streja; Kamyar Kalantar-Zadeh; Csaba P Kovesdy; Miklos Z Molnar Journal: Nephron Date: 2020-05-20 Impact factor: 2.847
Authors: Tarek Alhamad; Farrukh M Koraishy; Ngan N Lam; Sreelatha Katari; Abhijit S Naik; Mark A Schnitzler; Huiling Xiao; David A Axelrod; Vikas R Dharnidharka; Henry Randall; Rosemary Ouseph; Dorry L Segev; Daniel C Brennan; Radhika Devraj; Bertram L Kasiske; Krista L Lentine Journal: Transplantation Date: 2019-11 Impact factor: 4.939
Authors: Tarek Alhamad; Daniel C Brennan; Zaid Brifkani; Huiling Xiao; Mark A Schnitzler; Vikas R Dharnidharka; David Axelrod; Dorry L Segev; Krista L Lentine Journal: Transplantation Date: 2016-05 Impact factor: 4.939
Authors: Krista L Lentine; Ngan N Lam; Mark A Schnitzler; Amit X Garg; Huiling Xiao; Sheila E Leander; Daniel C Brennan; Sandra J Taler; David Axelrod; Dorry L Segev Journal: Clin Transplant Date: 2015-09-18 Impact factor: 2.863
Authors: Ngan N Lam; Mark A Schnitzler; David A Axelrod; Huiling Xiao; Mara McAdams-DeMarco; Dorry L Segev; Allan B Massie; Vikas R Dharnidharka; Abhijit S Naik; Abimereki D Muzaale; Gregory P Hess; Bertram L Kasiske; Krista L Lentine Journal: Clin Transplant Date: 2020-08-03 Impact factor: 2.863